![COVID-19 seroprevalance study collaborators have included: front row, l-r, Mark Williams, Ph.D., Joshua Kennedy, M.D., Laura James, M.D., and Katherine Caid, M.D.; middle row, Sandra McCullough, Justin Bean, Veronica Smith, Ben Amick, Ph.D., Moya Kouassi, Hoda Hagrass, M.D., Ph.D., Nathan Petty, Shana Owens, Victor Cardenas, M.D., Ph.D., and Jing Jin; back row: Ericka Olgaard, D.O., Karl Boehme, Ph.D., Craig Forrest, Ph.D., and Ryan Mann.](https://tri.uams.edu/wp-content/uploads/2021/07/Sero-Team-masks-on-1024x418.jpg)
In this issue of The TRIbune, we look back at the significant collaborative effort to conduct a statewide antibody test for SARS-CoV-2. The study began with a phone call to Josh Kennedy, M.D., from the Arkansas Department of Health and quickly evolved into a major project.
Results of the seroprevalence study were published this week in the public database medRxiv (med archive).
We also name our newest Health Sciences Innovation and Entrepreneurship (HSIE) Postdoctoral Training Program scholars as well as the 2021 TRI Career Development Scholars Program recipients.
Our TRI Study of the Month features Johnathan Goree, M.D.
Read The TRIbune.